GREENLAND MINES LTD Derivative Liability
GREENLAND MINES LTD (GRML) had Derivative Liability of $74.20 thousand as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2023-11-17
- 2023-09-30: Derivative Liability $74.20K.
- 2023-06-30: Derivative Liability $63.60K.
- 2023-03-31: Derivative Liability $42.40K.
- 2022-12-31: Derivative Liability $31.80K.
| Period end | Derivative Liability |
|---|---|
| 2023-09-30 | $74.20K 10-Q · filed 2023-11-17 |
| 2023-06-30 | $63.60K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $42.40K 10-Q · filed 2023-05-24 |
| 2022-12-31 | $31.80K 10-Q · filed 2023-11-17 |
| 2022-09-30 | $31.80K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $710.20K 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |